AXSM vs TFC · rev $409.6M vs rev $11.82B
Axsome Therapeutics Inc (AXSM) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
TFC (TFC) common stock.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported TFC revenue for 2026-06-30 was $11.82B. Net income was $3.03B. TFC currently screens at market cap $0.
AXSM currently screens at market cap $11.96B. TFC currently screens at market cap $0.
Not investment advice. Open the AXSM and TFC stock pages for the full models.
Not investment advice.